XML 115 R98.htm IDEA: XBRL DOCUMENT v3.20.4
NET LOSS PER SHARE (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
NET LOSS PER SHARE    
Schedule of computation of our basic and diluted net loss per share attributable to common shareholders

The following table sets forth the computation of our basic and diluted net loss per share attributable to common shareholders for the nine months ended September 30, 2020 and 2019 (in thousands):

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended September 30,

 

    

2020

    

2019

Basic net loss per share:

 

 

  

 

 

  

Numerator:

 

 

  

 

 

  

Net Loss

 

$

(198,968)

 

$

(247,448)

Minus: Net income attributed to noncontrolling interests

 

 

 —

 

 

1,847

Net loss attributable to common shareholders – basic

 

$

(198,968)

 

$

(249,295)

Denominator:

 

 

  

 

 

  

Weighted average shares outstanding – basic and diluted

 

 

53,110

 

 

48,786

Basic net loss per share

 

$

(3.75)

 

$

(5.11)

Diluted net loss per share:

 

 

  

 

 

  

Numerator:

 

 

  

 

 

  

Net Loss

 

$

(198,968)

 

$

(247,448)

Minus: Net income attributed to noncontrolling interests

 

 

 —

 

 

1,847

Minus: Gain on liability-classified warrants

 

 

 —

 

 

8,402

Net loss attributable to common shareholders – diluted

 

$

(198,968)

 

$

(257,697)

Denominator:

 

 

  

 

 

  

Weighted average shares outstanding – basic and diluted

 

 

53,110

 

 

48,786

Diluted net loss per share

 

$

(3.75)

 

$

(5.28)

 

The following table sets forth the computation of our basic and diluted net loss per share attributable to common shareholders for the years ended December 31, 2019, 2018, and 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Years Ended December 31,

 

    

2019

    

2018

    

2017

Basic net loss per share:

 

 

  

 

 

  

 

 

  

Numerator:

 

 

  

 

 

  

 

 

  

Net loss

 

$

(339,170)

 

$

(239,929)

 

$

(84,767)

Minus: Deemed dividend

 

 

 —

 

$

7,224

 

 

 —

Minus: Net income attributable to noncontrolling interests

 

$

1,847

 

$

1,362

 

$

62

Net loss attributable to common shareholders – basic

 

$

(341,017)

 

$

(248,515)

 

$

(84,829)

Denominator:

 

 

  

 

 

  

 

 

  

Weighted average shares outstanding – basic and diluted

 

 

49,444

 

 

48,570

 

 

39,930

Basic and diluted net loss per share

 

$

(6.90)

 

$

(5.12)

 

$

(2.12)

Diluted net loss per share:

 

 

  

 

 

  

 

 

  

Numerator:

 

 

  

 

 

  

 

 

  

Net loss

 

$

(339,170)

 

$

(239,929)

 

$

(84,767)

Minus: Deemed dividend

 

 

 —

 

$

7,224

 

 

 —

Minus: Net income attributable to noncontrolling interests

 

$

1,847

 

$

1,362

 

$

62

Minus: Gain on liability-classified warrants

 

$

8,132

 

 

 —

 

 

 —

Net loss attributable to common shareholders – diluted

 

$

(349,149)

 

$

(248,515)

 

$

(84,829)

Denominator:

 

 

  

 

 

  

 

 

  

Weighted average shares outstanding – basic and diluted

 

 

49,444

 

 

48,570

 

 

39,930

Basic and diluted net loss per share – diluted

 

$

(7.06)

 

$

(5.12)

 

$

(2.12)

 

Schedule of anti-dilutive securities were not included in the computation of diluted shares outstanding

The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive for the periods presented, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period (in thousands):

 

 

 

 

 

 

 

 

For the Nine Months Ended September 30,

 

    

2020

    

2019

Common Stock Warrants

 

2,084

 

2,081

Series D Preferred Stock Warrants

 

300

 

 —

Series E Preferred Stock Warrants

 

225

 

75

RSUs

 

19,662

 

8,736

Options

 

18,725

 

22,760

Unvested Shares from Early Exercise

 

46

 

220

Restricted Shares

 

1,520

 

2,288

Redeemable convertible preferred stock

 

194,384

 

189,064

Total anti-dilutive securities

 

236,946

 

225,224

 

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period (in thousands):

 

 

 

 

 

 

 

 

 

 

For the Years Ended December 31,

 

    

2019

    

2018

    

2017

Common Stock Warrants

 

2,084

 

2,081

 

853

Series D Preferred Stock Warrants

 

300

 

5,620

 

 —

Series E Preferred Stock Warrants

 

75

 

 —

 

 —

RSUs

 

14,070

 

564

 

 —

Options

 

22,633

 

27,243

 

24,897

Unvested Shares from Early Exercise

 

116

 

693

 

1,611

Restricted Shares

 

2,281

 

1,851

 

997

Redeemable convertible preferred stock

 

194,384

 

167,841

 

92,417

Total anti-dilutive securities

 

235,943

 

205,893

 

120,775